NANOTHERAPEUTICS

nanotherapeutics-logo

Nanotherapeutics is a privately held specialty biopharmaceutical company with full product development, cGMP manufacturing capabilities, and a proprietary pipeline. The Company's technologies can be used with all drug types ranging from small molecules to proteins and peptides. These technologies can be employed with new chemical entities or with generic drugs and can be used with the spectrum of existing drug types ranging from small synthetic molecules to large recombinant macromolecules.

#SimilarOrganizations #People #Financial #Website #More

NANOTHERAPEUTICS

Industry:
Biopharma Biotechnology Manufacturing

Founded:
1999-01-01

Address:
Alachua, Florida, United States

Country:
United States

Website Url:
http://www.nanotherapeutics.com

Total Employee:
51+

Status:
Active

Contact:
(386)462-9663

Email Addresses:
[email protected]

Total Funding:
66.5 M USD

Technology used in webpage:
Domain Not Resolving Euro IPv6 Google Maps Google Maps API Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS ReCAPTCHA V2 WooCommerce


Similar Organizations

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

Current Employees Featured

james-matthew_image

James Matthew
James Matthew President, Chief Executive Officer and Chief Financial Officer @ Nanotherapeutics
President, Chief Executive Officer and Chief Financial Officer

bärbel-eppler_image

Bärbel Eppler
Bärbel Eppler Sr. VP Preclinical and QA @ Nanotherapeutics
Sr. VP Preclinical and QA
2001-01-01

james-d-talton_image

James D Talton
James D Talton Co-founder, President and Chief Executive Officer @ Nanotherapeutics
Co-founder, President and Chief Executive Officer

not_available_image

James Kirk
James Kirk Vice President, Engineering @ Nanotherapeutics
Vice President, Engineering

william-hensler_image

William Hensler
William Hensler Vice President, Global Head of Operations @ Nanotherapeutics
Vice President, Global Head of Operations

not_available_image

Gary Ascani
Gary Ascani VP, Business Development @ Nanotherapeutics
VP, Business Development
2010-03-01

robert-house_image

Robert House
Robert House Senior VP, Government Contracts @ Nanotherapeutics
Senior VP, Government Contracts
2014-06-01

eugene-johnston_image

Eugene Johnston
Eugene Johnston CQE/CQA, Vice President, Quality Assurance @ Nanotherapeutics
CQE/CQA, Vice President, Quality Assurance

andrew-graham_image

Andrew Graham
Andrew Graham Vice President of Manufacturing @ Nanotherapeutics
Vice President of Manufacturing
2015-01-01

Founder


james-d-talton_image

James D Talton

Investors List

white-oak-global-advisors_image

White Oak Global Advisors

White Oak Global Advisors investment in Debt Financing - Nanotherapeutics

trinity-capital-investment_image

Trinity Capital

Trinity Capital investment in Debt Financing - Nanotherapeutics

herculescapital_image

Hercules Capital

Hercules Capital investment in Debt Financing - Nanotherapeutics

Official Site Inspections

http://www.nanotherapeutics.com

Unable to get host informations!!!

Loading ...

More informations about "Nanotherapeutics"

Nanoscope Therapeutics

Nanoscope is focused on proprietary ambient light activated optogenetic therapy to restore vision in people suffering from all forms of Retinitis Pigmentosa, Stargardt and other inherited retinal …See details»

Nanotherapeutics - Crunchbase Company Profile

Nanotherapeutics is a privately held specialty biopharmaceutical company with full product development, cGMP manufacturing capabilities, and a proprietary pipeline. The Company's technologies can be used with all drug types ranging …See details»

Nanotherapeutics, Inc. - Devex

Learn more about Nanotherapeutics, Inc.'s jobs, projects, latest news, contact information and geographical presence. Nanotherapeutics was founded in 1999 as an integrated …See details»

Nanotherapeutics, Inc. - InterNano

Nanotherapeutics has significant expertise in product formulation, pre-clinical and clinical development, scale-up and cGMP manufacturing, utilizing established and proprietary …See details»

Nanotherapeutics: An insight into healthcare and multi …

Jan 1, 2018 · Owing to the revolutionary implications in drug delivery and gene therapy, nanotherapeutics has gained increasing research interest in the current medical sector of the …See details»

Nanomedicine in cancer therapy | Signal Transduction and

Aug 7, 2023 · Recent advances in nanotechnology, accompanied by our growing understanding of cancer biology and nano-bio interactions, have led to the development of a series of …See details»

Cancer nanomedicine: progress, challenges and opportunities

Nov 11, 2016 · This Review summarizes progress in applying nanotechnology to cancer treatment and discusses the challenges of clinical translation and opportunities to develop …See details»

Nano-Based Approved Pharmaceuticals for Cancer Treatment: …

Nanotechnology, through the development of nanoscale-based pharmaceuticals, has emerged to provide new and innovative drugs to overcome these limitations. In this review, we provide an …See details»

Nanotherapeutics in the EU: an overview on current state and …

Feb 19, 2014 · In this paper, we review the liposome-, nanocrystal-, virosome-, polymer therapeutic-, nanoemulsion-, and nanoparticle-based approaches to nanotherapeutics, which …See details»

Nanotherapeutics and the Brain - PMC - National Center for ...

Jun 6, 2022 · We explore the challenges of drug delivery to the brain and the ways in which nanotherapeutics can overcome these challenges. We provide a summary and overview of …See details»

Cancer nanomedicine: a review of nano-therapeutics and …

Since 1930, chemotherapeutics have been used to treat cancer. However, such conventional treatments are associated with pain, side effects, and a lack of targeting. Nanomedicines are …See details»

Designing nanotheranostics with machine learning - Nature

Oct 3, 2024 · ML offers unique opportunities for nanotheranostics, including guiding nanoparticle synthesis, decoding nano–bio interactions, and improving nanodiagnoses and nanotherapeutics.See details»

Progress, challenges, and future of nanomedicine - ScienceDirect

Dec 1, 2020 · More importantly, many nanotherapeutics have been approved for clinical use or are being investigated in clinical trials, including polymeric, liposomal, nanocrystal, protein …See details»

Nanoparticles for Cancer Therapy: Current Progress and Challenges

Dec 5, 2021 · This review discusses numerous types of nanoparticles, targeting mechanisms, and approved nanotherapeutics for oncological implications in cancer treatment. Further, we also …See details»

Nanotherapeutics Plus Immunotherapy in Oncology: Who Brings …

Oct 28, 2022 · While the number of oncology-related nanotherapeutics and immunotherapies is constantly increasing, cancer patients still suffer from a lack of efficacy and treatment …See details»

Nanoparticle therapeutics: an emerging treatment modality for …

Newer nanoparticle therapeutics are showing enhanced efficacy with lower side effects than traditional small-molecule chemotherapeutics in early clinic studies, and are doing so without...See details»

Advanced Healthcare Materials : Nanotherapeutics - Wiley Online …

Mar 11, 2019 · In this virtual issue of Advanced Healthcare Materials, we highlight some of the recent reports and developments in these four nanotherapeutic features, showcasing how …See details»

Nanotherapeutics in the EU: an overview on current state and …

In this paper, we review the liposome-, nanocrystal-, virosome-, polymer therapeutic-, nanoemulsion-, and nanoparticle-based approaches to nanotherapeutics, which represent the …See details»

The current landscape of nucleic acid therapeutics - Nature

May 31, 2021 · Here, we review four platform technologies that have enabled the clinical translation of nucleic acid therapeutics: antisense oligonucleotides, ligand-modified small …See details»

linkstock.net © 2022. All rights reserved